Consensus on potential biomarkers developed for use in clinical tests for schizophrenia.
Ping LinJunyu SunXiaoyan LouDan LiYun ShiZhenhua LiPeijun MaPing LiShuzi ChenWeifeng JinShuai LiuQing ChenQiong GaoLili ZhuJie XuMengyuan ZhuMengxia WangKangyi LiangLing ZhaoHuabin XuKe DongQingtian LiXunjia ChengJinghong ChenXiaokui GuoPublished in: General psychiatry (2022)
Further efforts are needed to identify schizophrenia-specific genetic and epigenetic markers for precise diagnosis, differential diagnosis and ethnicity-specific markers for the Chinese population. The development of novel laboratory techniques is making it possible to use these biomarkers clinically to diagnose disease.